Charles V. Vorhees

Charles V. Vorhees is a Professor in the Department of Pediatrics at the University of Cincinnati College of Medicine, with primary research conducted at Cincinnati Children's Hospital. His laboratory focuses on developmental neurotoxicology and neuroteratology, investigating how early-life exposures to pharmaceuticals and environmental agents impact brain development and behavior.

Dr. Vorhees' research spans multiple critical areas in neurotoxicology:

• Antidepressant Risks: Demonstrated that third-trimester-equivalent SSRI exposure causes learning deficits in rat offspring and serotonin reductions, with clinical correlations to increased Autism Spectrum Disorder risk
• Methamphetamine Neurotoxicity: Extensive work on how developmental methamphetamine exposure affects monoamine systems, spatial learning, and memory across different developmental periods
• Novel Assessment Methods: Developed improved approaches for developmental neurotoxicity testing that better align rodent models with human child outcomes

His publication record shows consistent high-impact research since the 1970s, with recent work focusing on molecular mechanisms of neurotoxicity, including phosphodiesterase enzymes, tubulin mutations, and creatine metabolism. Dr. Vorhees maintains a long-standing collaboration with Dr. Michael T. Williams, with whom he has co-authored over 100 publications.

Dr. Vorhees has contributed significantly to regulatory science through commentaries on developmental neurotoxicity testing standards, advocating for more comprehensive cognitive assessment in regulatory studies to better protect child health.

His laboratory employs sophisticated behavioral paradigms including the Cincinnati Water Maze for egocentric navigation and Morris Water Maze for allocentric learning, with particular expertise in dissecting how developmental exposures alter specific cognitive domains rather than producing generalized deficits.